Revalesio, a clinical-stage pharmaceutical company developing treatments for acute and chronic neurological disorders, today announced data from a post hoc analysis of its completed Phase 2 RESCUE ...

Viasat, Inc. VSAT reported mixed fourth-quarter fiscal 2025 results, wherein the adjusted earnings missed the Zacks Consensus ...

Workday, Inc. WDAY has announced a powerful expansion of its AI-driven capabilities with a new wave of Illuminate Agents, ...